Aims Since its emergence in early 2020, the novel severe acute respiratory syndrome
coronavirus 2 causing coronavirus disease 2019 (COVID-19) has reached pandemic levels …

Transcatheter aortic valve replacement (TAVR) has become a mainstay in treatment for
patients with severe aortic stenosis who are considered high-risk surgical candidates. The …

Objectives This study sought to report the largest series of patients receiving a surgical
reoperation after transcatheter aortic valve replacement (TAVR) using the Society of …

Background Recent trends, including survival beyond 30 days, in aortic valve replacement
(AVR) following the expansion of indications for transcatheter aortic valve replacement …

Transcatheter aortic valve replacement (TAVR) has grown exponentially since 2011 and is
now preferred over surgical aortic valve replacement in most patients with severe aortic …

Valve-in-valve (ViV) transcatheter aortic valve implantation (TAVI) for a failing prosthesis is
an appealing alternative to redo surgical AVR. We utilized data from the US National …

Aortic stenosis (AS) and regurgitation (AR) may be treated with surgical aortic valve
replacement (SAVR), transcatheter AVR (TAVR), or medical therapy (MT). Data are lacking …

Background In the recent decades, the development of novel digital health technologies
enables doctors to monitor ECG and vital signs remotely. But the data on applying the …

Over the last decades, transcatheter aortic valve implantation (TAVI) or replacement (TAVR)
has become a potential, widely accepted, and effective method of treating aortic stenosis in …

Data regarding the clinical outcomes of transcatheter aortic valve replacement (TAVR) vs.
surgical aortic valve replacement (SAVR) in cardiac amyloidosis are lacking. Our study …